David Lim
Instructor David Lim
Product Id 600937
Duration 60 Minutes  
Version Recorded
Original Price $295
Special Offer Price $10
Refund Policy
Access recorded version only for one participant; unlimited viewing for 6 months

FDA-Compliant Medical Device Reporting (MDR)

Overview:

This webinar is intended to demonstrate how to define, document, implement, and maintain the necessary procedures for medical device reporting. In the United States, since December 13, 1984, the Food and Drug Administration (FDA) Medical Device Reporting (MDR) regulations have required firms who have received complaints of device malfunctions, serious injuries or deaths associated with medical devices to notify FDA of the incident.

MDR is the mechanism for the FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so they can be detected and corrected quickly. It is critical to understand how to define, document, implement, and maintain the procedures for MDR.

This webinar will greatly help device industry and relevant professionals understand how to define, document, implement, and maintain the procedures for MDR.

Why Should You Attend: IDevice manufacturers are required to establish and maintain a medical device adverse event reporting system, commonly known as Medical Device Reporting. This webinar will demonstrate how to define, document, implement, and maintain the necessary procedures for medical device reporting.

Areas Covered in the Session:

  • Relevant Statutes and FDA Regulations
  • Definitions
  • Regulatory Requirements for Medical Device Reporting (MDR)
  • Requirements to Be Addressed in the Procedures
  • How to Fill Out MDR Forms
  • How and Where to Report Medical Device Adverse Events
  • Reporting Requirements for the User Facilities, Manufacturers, and Importers
  • Enforcements: Numerous Case Studies

Who Will Benefit:
  • Complaint Handling, Risk Management Managers and Directors
  • Compliance Officers and Legal Counsel
  • Regulatory Affairs
  • Clinical Affairs
  • Quality Assurance, Quality Control, and Quality Systems
  • Research and Development
  • Product and Development
  • Marketing
  • Site Managers and Consultants.
  • Contract Manufacturing Organization
  • Contract Research Organization
  • Senior and Executive Management
  • Contractors and Subcontractors.

Speaker Profile
Dr. Lim obtained his Ph.D. in biological sciences at the University of Missouri-Columbia and published his thesis research in the prestigious journal “Science.” Since then, Dr. Lim has held various positions at Duke, US National Laboratories, Intrexon Corporation, Terumo, US FDA/CDRH, and EraGen Biosciences, Inc., A Luminex Company. In 2009, Dr. Lim served as a member during the FDA’s Transparency Public Meeting. Prior to founding his own consulting firm (www.RegulatoryDoctor.com), Dr. Lim was Senior Vice President of Scientific and Regulatory Affairs at Aquavit Pharmaceuticals, Inc. in New York, wherein Dr. Lim provided inspiring and actionable solutions for sustainable business operation. Dr. Lim as Regulatory Doctor provides practical, actionable and strategic solutions integrated with emotional intelligence (EQ) skills for all aspects of global regulatory, quality, clinical and compliance matters. Over the years, Dr. Lim has analyzed over 1,000 FDA warning letters. Dr. Lim has also attended more than 50 FDA Advisory Panel Meetings and analyzed the subject matters and decision-making processes in detail. Dr. Lim is familiar with more than 200 medical products (medical devices including IVD products, biologics, drugs and combination products). Dr. Lim is a certified professional for regulatory affairs (RAC) and also is a certified quality auditor (CQA) by the American Society for Quality (ASQ). Dr. Lim is an auditor, regulatory coach, consultant and instructor for global matters pertaining to regulatory affairs and compliance, quality and clinical affairs.

Sign Up for Our Newsletter